The Quantum Leap: Redefining the Speed of Discovery
We are dedicated to solving a fundamental challenge of the human experience: Longevity. Traditional drug discovery is a multi-billion-dollar cycle of trial and error that often takes over a decade to yield results. We are disrupting this cycle by migrating chemical experimentation from the wet-lab into the digital realm.
By leveraging Quantum-Assisted Rational Drug Design, we simulate molecular behavior with subatomic precision. This creates a digital shortcut that identifies the exact pathways to extend the healthy human lifespan, bypasses the costly R&D dead-ends that stall medical progress, and accelerates the journey from hypothesis to therapeutic solution in a fraction of the traditional timeline.
Leadership in Molecular Innovation
Dr. Gregory Chass & Dr. David Setiadi
Our hardware and drug discovery initiatives are spearheaded by the formidable duo of Dr. Gregory Chass and Dr. David Setiadi. Together, they bring a rare synergy of deep molecular science expertise and computational rigor.
Dr. Chass and Dr. Setiadi lead the architecture of our Quantum Chemical Modeling platform. This is powered by custom hardware specifically optimized to simulate complex molecular environments at the electronic level—an area where traditional computing hits a "complexity wall." By bridging the gap between theoretical physics and medicinal chemistry, they are positioned to accelerate our pipeline, transforming how we identify, model, and validate next-generation therapeutics with atomic-scale accuracy.